US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Kairos Acquisition Corp.

10.08

+0.0000

Volume:- -

Turnover:- -

Market Cap:347.59M

PE:26.48

High:10.08

Open:10.08

Low:10.08

Close:10.08

Loading ...

Overview Company News Filings

Kairos Minerals Announces Cessation of Securities

DePIN Project Kairos announces the completion of its seed round financing, with Vertex Capital, HKIFS, and Oaktree Capital co-leading the investment.

Kairos Minerals Launches Major Drilling Program at Mt York Gold Project

Kairos Pharma, Ltd. Announces Data to be Presented at the American Society of Clinical Oncology (ASCO) 2025 Annual Meeting

Kairos Pharma Ltd. Provides Letter to Stockholders

Kairos Pharma files to sell 16.29M shares of common stock for holders

Kairos Pharma Is Maintained at Buy by D. Boral Capital

HC Wainwright Initiates Kairos Pharma at Buy With $12 Price Target

MT Newswires Live

Kairos Pharma: Promising Oncology Pipeline and Strategic Advancements Drive Buy Rating

Kairos Pharma: Promising Innovations in Cancer Drug Resistance and Immune Enhancement

Kairos Pharma Initiated at Buy by HC Wainwright & Co.

Kairos Pharma initiated with a Buy at H.C. Wainwright

Kairos Pharma Is Maintained at Buy by D. Boral Capital

Kairos Pharma Ltd. Highlights Participation in Recent and Upcoming Scientific and Industry Events

Kairos Pharma Initiated at Buy by Maxim Group

Kairos Pharma initiated with a Buy at Maxim

Kairos Pharma Is Maintained at Buy by D. Boral Capital

Kairos Pharma Ltd. Announces Peer Reviewed Publication Highlighting Potentially Groundbreaking Discovery in Overcoming Drug Resistance in Non-Small Cell Lung Cancer

Kairos Pharma Is Maintained at Buy by D. Boral Capital

Kairos Pharma Presents Preclinical Data on its Investigational Compounds KROS 101 and KROS 401 Further Supporting Both Compounds’ Potential as Therapeutics for Melanoma and Glioblastoma

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/KAIR/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"KAIR","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KAIR\",,,,,undefined,":{"symbol":"KAIR","market":"US","secType":"STK","nameCN":"Kairos Acquisition Corp.","latestPrice":10.075,"timestamp":1688155200000,"preClose":10.075,"halted":0,"volume":0,"delay":0,"floatShares":19423255,"shares":34500000,"eps":0.380483,"marketStatus":"Market Closed","change":0,"latestTime":"06-30 16:00:00 EDT","open":10.075,"high":10.075,"low":10.075,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.380483,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1746432000000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":10.075,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KAIR\",,,,,undefined,":{"symbol":"KAIR","floatShares":19423255,"roa":"-0.96%","roe":"--","lyrEps":0.243197,"shares":34500000,"dividePrice":0,"high":10.075,"amplitude":0,"preClose":10.075,"low":10.075,"week52Low":9.705,"pbRate":"-33.11","week52High":10.08,"institutionHeld":0,"latestPrice":10.075,"eps":0.380483,"divideRate":0,"volume":0,"delay":0,"ttmEps":0.380483,"open":10.075,"prevYearClose":10.075},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"KAIR\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2532023842","title":"Kairos Minerals Announces Cessation of Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=2532023842","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532023842?lang=en_us&edition=fundamental","pubTime":"2025-05-01 15:11","pubTimestamp":1746083482,"startTime":"0","endTime":"0","summary":"Kairos Minerals ( ($AU:KAI) ) has shared an announcement. Kairos Minerals Limited announced the cessation of 12,000,000 securities due to the lapse...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/kairos-minerals-announces-cessation-of-securities?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/kairos-minerals-announces-cessation-of-securities?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MTX","KAIR","BK4109"],"gpt_icon":0},{"id":"2531147080","title":"DePIN Project Kairos announces the completion of its seed round financing, with Vertex Capital, HKIFS, and Oaktree Capital co-leading the investment.","url":"https://stock-news.laohu8.com/highlight/detail?id=2531147080","media":"Blockbeats","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531147080?lang=en_us&edition=fundamental","pubTime":"2025-04-30 18:28","pubTimestamp":1746008880,"startTime":"0","endTime":"0","summary":"BlockBeats News, April 30th, according to official sources, the DePIN project Kairos has completed its seed round financing, led by Vertex Capital , HKIFS , and Oaktree Capital Management  jointly.Kairos is focused on building a DePIN resource network for the AI Agent era, aiming to bridge the collaborative path between edge hardware and intelligent body computing. Its flagship product is the world's first mass-produced blood pressure monitoring smart ring, accompanied by a distributed health data computing ecosystem.It is reported that Kairos has achieved the large-scale implementation of medical-grade sensor modules, and the core team has a background in chip design and manufacturing. The project's data encryption architecture complies with the HIPAA medical compliance standard, demonstrating strong hardware delivery capabilities and a foundation of data security. Additionally, Kairos holds multiple core technology patents, including dual-system monitoring of blood pressure/blood lip","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.theblockbeats.info//en/flash/291895","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"theblockbeats_live","symbols":["IE00BFTCPJ56.SGD","BK4138","IE0002141913.USD","KAIR","BK4532","SGXZ57979304.SGD","VERX","SG9999001176.USD","LU1559883803.SGD","IE0002270589.USD","LU1035775433.USD","LU1093756325.SGD","LU1069344957.HKD","LU2362540622.SGD","LU1585245621.USD","LU0566484027.USD","IE00B894F039.SGD","SG9999013999.USD","IE00B19Z9Z06.USD","BK4023","IE00B2B36J28.USD","BK4139","BK4585","BK4533","LU1815336091.USD","VRTX","BK4567","UK","IE00B19Z3B42.SGD","IE00BJJMRZ35.SGD","IE00BZ9MQY76.HKD","BK4233","LU2236285917.USD","IE00B4R5TH58.HKD","VTNR","LU0058720904.USD","IE00B19Z9P08.USD","LU0889565916.HKD","SG9999001176.SGD","LU0289739699.SGD","LU0234570918.USD","LU2362541513.USD","LU2237438978.USD","BK4205","LU2362541273.HKD","IE00BJT1NW94.SGD","OACB.U","LU0757428866.USD","LU2324357040.USD","IE00B19Z3581.USD"],"gpt_icon":0},{"id":"2531089292","title":"Kairos Minerals Launches Major Drilling Program at Mt York Gold Project","url":"https://stock-news.laohu8.com/highlight/detail?id=2531089292","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531089292?lang=en_us&edition=fundamental","pubTime":"2025-04-29 08:20","pubTimestamp":1745886050,"startTime":"0","endTime":"0","summary":"Kairos Minerals ( ($AU:KAI) ) has issued an announcement. Kairos Minerals Ltd has commenced its largest drilling program to date at the Mt York Gol...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/kairos-minerals-launches-major-drilling-program-at-mt-york-gold-project?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/kairos-minerals-launches-major-drilling-program-at-mt-york-gold-project?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["KAIR","BK4109","MTX"],"gpt_icon":0},{"id":"2530097104","title":"Kairos Pharma, Ltd. Announces Data to be Presented at the American Society of Clinical Oncology (ASCO) 2025 Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2530097104","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530097104?lang=en_us&edition=fundamental","pubTime":"2025-04-28 20:00","pubTimestamp":1745841600,"startTime":"0","endTime":"0","summary":"LOS ANGELES, April 28, 2025----Kairos Pharma, Ltd. , a clinical stage biopharmaceutical company, announces it will be presenting at the American Society of Clinical Oncology  2025 Annual Meeting to be held May 30-June 3, 2025 at McCormick Place, Chicago, Ill.John Yu, M.D., Kairos CEO commented, \"We look forward to the opportunity to continue to share data regarding our platform assets at one of the most prestigious oncology meetings in the world. We believe that KROS 101 has the potential to help optimize cancer treatment and we look forward to discussing our findings with the medical and scientific communities.\"","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/kairos-pharma-ltd-announces-data-120000153.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4117","BK4139","BK4107","AFG","KAIR","KAPA"],"gpt_icon":0},{"id":"2529098694","title":"Kairos Pharma Ltd. Provides Letter to Stockholders","url":"https://stock-news.laohu8.com/highlight/detail?id=2529098694","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529098694?lang=en_us&edition=fundamental","pubTime":"2025-04-24 20:00","pubTimestamp":1745496000,"startTime":"0","endTime":"0","summary":"LOS ANGELES, April 24, 2025----Kairos Pharma, Ltd. , a clinical stage biopharmaceutical company, today provides a letter to stockholders from CEO John Yu, M.D.:. As we reflect on the Company’s progress before and after our initial public offering and listing on the NYSE American stock exchange, I am excited about what the future holds.Despite recent economic headwinds, we remain financially strong due to our recent private placement and judicious use of funds with non-dilutive funding. Thank you for your continued support and confidence in our mission. We look forward to providing you with regular updates on our progress","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/kairos-pharma-ltd-provides-letter-120000161.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["KAPA","BK4139","KAIR"],"gpt_icon":0},{"id":"2529373311","title":"Kairos Pharma files to sell 16.29M shares of common stock for holders","url":"https://stock-news.laohu8.com/highlight/detail?id=2529373311","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529373311?lang=en_us&edition=fundamental","pubTime":"2025-04-22 18:10","pubTimestamp":1745316635,"startTime":"0","endTime":"0","summary":"06:05 EDT Kairos Pharma (KAPA) files to sell 16.29M shares of common stock for holders Published first on TheFly – the ultimate source for real-tim...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/kairos-pharma-files-to-sell-16-29m-shares-of-common-stock-for-holders?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/kairos-pharma-files-to-sell-16-29m-shares-of-common-stock-for-holders?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","KAPA","KAIR"],"gpt_icon":0},{"id":"2528713034","title":"Kairos Pharma Is Maintained at Buy by D. Boral Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2528713034","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528713034?lang=en_us&edition=fundamental","pubTime":"2025-04-17 19:36","pubTimestamp":1744889760,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/KAPA/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 17, 2025 07:36 ET (11:36 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KAPA","KAIR"],"gpt_icon":0},{"id":"2527625213","title":"HC Wainwright Initiates Kairos Pharma at Buy With $12 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2527625213","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527625213?lang=en_us&edition=fundamental","pubTime":"2025-04-16 19:59","pubTimestamp":1744804785,"startTime":"0","endTime":"0","summary":"HC Wainwright Initiates Kairos Pharma at Buy With $12 Price Target","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["KAIR","KAPA"],"gpt_icon":0},{"id":"2527939382","title":"Kairos Pharma: Promising Oncology Pipeline and Strategic Advancements Drive Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2527939382","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527939382?lang=en_us&edition=fundamental","pubTime":"2025-04-16 18:16","pubTimestamp":1744798612,"startTime":"0","endTime":"0","summary":"Analyst Joseph Pantginis from H.C. Wainwright reiterated a Buy rating on Kairos Pharma, Ltd. (KAPA – Research Report) and keeping the price target ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/kairos-pharma-promising-oncology-pipeline-and-strategic-advancements-drive-buy-rating?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/kairos-pharma-promising-oncology-pipeline-and-strategic-advancements-drive-buy-rating?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["KAIR","KAPA"],"gpt_icon":0},{"id":"2524296998","title":"Kairos Pharma: Promising Innovations in Cancer Drug Resistance and Immune Enhancement","url":"https://stock-news.laohu8.com/highlight/detail?id=2524296998","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524296998?lang=en_us&edition=fundamental","pubTime":"2025-04-04 01:05","pubTimestamp":1743699915,"startTime":"0","endTime":"0","summary":"Kairos Pharma, Ltd. (KAPA) has received a new Buy rating, initiated by H.C. Wainwright analyst, Joseph Pantginis. Joseph Pantginis has given his Bu...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/kairos-pharma-promising-innovations-in-cancer-drug-resistance-and-immune-enhancement?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/kairos-pharma-promising-innovations-in-cancer-drug-resistance-and-immune-enhancement?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["KAIR","BK4139","KAPA"],"gpt_icon":0},{"id":"2524123770","title":"Kairos Pharma Initiated at Buy by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2524123770","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524123770?lang=en_us&edition=fundamental","pubTime":"2025-04-03 19:01","pubTimestamp":1743678060,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/KAPA/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 03, 2025 07:01 ET (11:01 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KAIR","KAPA","BK4139"],"gpt_icon":0},{"id":"2524234948","title":"Kairos Pharma initiated with a Buy at H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2524234948","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524234948?lang=en_us&edition=fundamental","pubTime":"2025-04-03 18:16","pubTimestamp":1743675383,"startTime":"0","endTime":"0","summary":"H.C. Wainwright initiated coverage of Kairos Pharma (KAPA) with a Buy rating and $12 price target The company’s oncology pipeline “could unlock the...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/kairos-pharma-initiated-with-a-buy-at-h-c-wainwright?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/kairos-pharma-initiated-with-a-buy-at-h-c-wainwright?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","KAIR","KAPA"],"gpt_icon":0},{"id":"2523499149","title":"Kairos Pharma Is Maintained at Buy by D. Boral Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2523499149","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523499149?lang=en_us&edition=fundamental","pubTime":"2025-03-31 20:39","pubTimestamp":1743424740,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/KAPA/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 31, 2025 08:39 ET (12:39 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KAPA","KAIR"],"gpt_icon":0},{"id":"2522531125","title":"Kairos Pharma Ltd. Highlights Participation in Recent and Upcoming Scientific and Industry Events","url":"https://stock-news.laohu8.com/highlight/detail?id=2522531125","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522531125?lang=en_us&edition=fundamental","pubTime":"2025-03-28 04:05","pubTimestamp":1743105900,"startTime":"0","endTime":"0","summary":"LOS ANGELES, March 27, 2025----Kairos Pharma, Ltd. , a clinical-stage biopharmaceutical company, highlights activity at recent scientific conferences and announces participation in future events.March 12, 2025 – Presented at the Society for Immunotherapy of Cancer Spring Scientific Meeting titled, \"Novel GITR Agonist KROS 101: A Dual Approach to Boost T Cell Immunity and Alter the Tumor Microenvironment\". March 17 to 19 – Participated in the BIO Europe conference in Milan, Italy. April 29 to May 1 – Kairos is slated to participate at the Fierce Pharma Engage Business Development and Licensing Meeting in San Diego. This press release contains \"forward-looking statements\" as defined in the Private Securities Litigation Reform Act of 1995. You can identify forward-looking statements as those that are not historical in nature, particularly those that use terminology such as \"may,\" \"should,\" \"expects,\" \"anticipates,\" \"contemplates,\" \"estimates,\" \"believes,\" \"plans,\" \"projected,\" \"predicts,\"","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/kairos-pharma-ltd-highlights-participation-200500406.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["KAIR","BK4139","KAPA"],"gpt_icon":0},{"id":"2522824589","title":"Kairos Pharma Initiated at Buy by Maxim Group","url":"https://stock-news.laohu8.com/highlight/detail?id=2522824589","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522824589?lang=en_us&edition=fundamental","pubTime":"2025-03-28 00:05","pubTimestamp":1743091500,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/KAPA/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 27, 2025 12:05 ET (16:05 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KAIR","BK4139","KAPA"],"gpt_icon":0},{"id":"2522437113","title":"Kairos Pharma initiated with a Buy at Maxim","url":"https://stock-news.laohu8.com/highlight/detail?id=2522437113","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522437113?lang=en_us&edition=fundamental","pubTime":"2025-03-27 19:40","pubTimestamp":1743075611,"startTime":"0","endTime":"0","summary":"Maxim analyst Jason McCarthy initiated coverage of Kairos Pharma (KAPA) with a Buy rating and $4 price target Published first on TheFly – the ultim...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/kairos-pharma-initiated-with-a-buy-at-maxim?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/kairos-pharma-initiated-with-a-buy-at-maxim?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["KAIR","KAPA","BK4139"],"gpt_icon":0},{"id":"2521952204","title":"Kairos Pharma Is Maintained at Buy by D. Boral Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2521952204","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521952204?lang=en_us&edition=fundamental","pubTime":"2025-03-21 03:49","pubTimestamp":1742500140,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/KAPA/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 20, 2025 15:49 ET (19:49 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KAPA","KAIR"],"gpt_icon":0},{"id":"2520100458","title":"Kairos Pharma Ltd. Announces Peer Reviewed Publication Highlighting Potentially Groundbreaking Discovery in Overcoming Drug Resistance in Non-Small Cell Lung Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2520100458","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520100458?lang=en_us&edition=fundamental","pubTime":"2025-03-20 19:30","pubTimestamp":1742470200,"startTime":"0","endTime":"0","summary":"LOS ANGELES, March 20, 2025----Kairos Pharma, Ltd. , a clinical-stage biopharmaceutical company, announces a peer-reviewed publication highlighting a potentially significant breakthrough in addressing drug resistance to EGFR-targeted therapies for non-small cell lung cancer  patients. Recent findings published in Drug Resistance Updates highlight the critical role of CD105  in mediating resistance to osimertinib, a frontline treatment for EGFR-mutant NSCLC. The study, titled, \"CD105 blockade restores osimertinib sensitivity in drug-resistant EGFR-mutant non-small cell lung cancer,\" demonstrated that CD105 expression is upregulated as a mechanism of therapy resistance, correlating with poor prognosis in patients.Based in Los Angeles, California, Kairos Pharma Ltd.  is at the forefront of oncology therapeutics, utilizing structural biology to overcome drug resistance and immune suppression in cancer. Our lead candidate, ENV105, is an antibody that targets CD105 – a protein identified as ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/kairos-pharma-ltd-announces-peer-113000085.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["KAPA","BK4139","KAIR"],"gpt_icon":0},{"id":"2514237837","title":"Kairos Pharma Is Maintained at Buy by D. Boral Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2514237837","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514237837?lang=en_us&edition=fundamental","pubTime":"2025-02-26 21:13","pubTimestamp":1740575580,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/KAPA/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 26, 2025 08:13 ET (13:13 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KAPA","KAIR"],"gpt_icon":0},{"id":"2514839973","title":"Kairos Pharma Presents Preclinical Data on its Investigational Compounds KROS 101 and KROS 401 Further Supporting Both Compounds’ Potential as Therapeutics for Melanoma and Glioblastoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2514839973","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514839973?lang=en_us&edition=fundamental","pubTime":"2025-02-26 20:00","pubTimestamp":1740571200,"startTime":"0","endTime":"0","summary":"LOS ANGELES, February 26, 2025----Kairos Pharma, Ltd. , a clinical-stage biopharmaceutical company, announced that the company presented preclinical data on its investigational compounds KROS 101 and KROS 401 during the American Association for Cancer Research Immuno-Oncology  conference held in Los Angeles from February 23-26, 2025. The data highlighted positive preclinical outcomes with the Company’s glucocorticoid-induced tumor necrosis factor receptor  agonist KROS101 in melanoma and glioblastoma as well as its peptide inhibitor for macrophages KROS 401 in glioma animal models.The second presentation, titled, \"Targeting M2 macrophage polarization: The anti-tumor effects of IL-4/IL-13 blocking peptide and iron oxide nanoparticles,\" demonstrated the Company’s peptide inhibitor KROS 401 may effectively reprogram macrophages – types of white blood cell of the innate immune system that engulf and digest pathogens, such as cancer cells, microbes, cellular debris and foreign substances – ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/kairos-pharma-presents-preclinical-data-120000742.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","KROS","KAIR","KAPA"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":46,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/KAIR\",params:#limit:5,,,undefined,":[{"market":"US","date":"2023-01-03","symbol":"KAIR","reason":null,"defaultRemindTime":1672756200000,"announcedDate":"2022-12-09","type":"delisting","dateTimestamp":1672722000000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"KAIR\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"KAIR\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/KAIR\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"KAIR","date":"2022-12-30","current":26.465036,"percent":0.788462,"low":-3152.741514,"twenty":-3123.993111,"median":-3101.633243,"eighty":41.121928,"high":58.491109,"avg":-1837.241689,"sd":1548.390193,"marketCap":347415000},"quantilePoints":[{"date":"2021-04-01","current":-3033.164824,"twenty":-3033.164824,"median":-3033.164824,"eighty":-3033.164824,"marketCap":327600000},{"date":"2021-04-09","current":-3146.35298,"twenty":-3133.575912,"median":-3122.395978,"eighty":-3108.021777,"marketCap":339825000},{"date":"2021-04-16","current":-3149.547247,"twenty":-3133.575912,"median":-3120.798845,"eighty":-3111.216044,"marketCap":340170000},{"date":"2021-04-23","current":-3146.35298,"twenty":-3146.35298,"median":-3131.978778,"eighty":-3111.216044,"marketCap":339825000},{"date":"2021-04-30","current":-3130.381645,"twenty":-3146.35298,"median":-3130.381645,"eighty":-3111.216044,"marketCap":338100000},{"date":"2021-05-07","current":-3123.993111,"twenty":-3146.35298,"median":-3130.381645,"eighty":-3114.410311,"marketCap":337410000},{"date":"2021-05-14","current":-3117.604578,"twenty":-3146.35298,"median":-3130.381645,"eighty":-3114.410311,"marketCap":336720000},{"date":"2021-05-21","current":-3096.841842,"twenty":-3146.35298,"median":-3130.381645,"eighty":-3110.577191,"marketCap":334477500},{"date":"2021-05-28","current":-3085.661908,"twenty":-3138.686739,"median":-3123.993111,"eighty":-3103.230376,"marketCap":333270000},{"date":"2021-06-04","current":-3111.216044,"twenty":-3135.492472,"median":-3120.798845,"eighty":-3103.230376,"marketCap":336030000},{"date":"2021-06-11","current":-3123.993111,"twenty":-3133.575912,"median":-3123.993111,"eighty":-3105.146936,"marketCap":337410000},{"date":"2021-06-18","current":-3111.216044,"twenty":-3133.575912,"median":-3120.798845,"eighty":-3103.230376,"marketCap":336030000},{"date":"2021-06-25","current":-3101.633243,"twenty":-3133.575912,"median":-3117.604578,"eighty":-3101.633243,"marketCap":334995000},{"date":"2021-07-02","current":-3101.633243,"twenty":-3133.575912,"median":-3117.604578,"eighty":-3101.633243,"marketCap":334995000},{"date":"2021-07-09","current":-3098.438976,"twenty":-3133.575912,"median":-3114.410311,"eighty":-3098.438976,"marketCap":334650000},{"date":"2021-07-16","current":-3101.633243,"twenty":-3133.575912,"median":-3111.216044,"eighty":-3098.438976,"marketCap":334995000},{"date":"2021-07-23","current":-3104.82751,"twenty":-3131.020498,"median":-3108.021777,"eighty":-3098.438976,"marketCap":335340000},{"date":"2021-07-30","current":-3098.438976,"twenty":-3130.381645,"median":-3108.021777,"eighty":-3098.438976,"marketCap":334650000},{"date":"2021-08-06","current":-3085.661908,"twenty":-3130.381645,"median":-3108.021777,"eighty":-3098.438976,"marketCap":333270000},{"date":"2021-08-13","current":-3104.82751,"twenty":-3130.381645,"median":-3108.021777,"eighty":-3098.438976,"marketCap":335340000},{"date":"2021-08-20","current":-3101.633243,"twenty":-3130.381645,"median":-3104.82751,"eighty":-3098.438976,"marketCap":334995000},{"date":"2021-08-27","current":-3098.438976,"twenty":-3129.103938,"median":-3104.82751,"eighty":-3098.438976,"marketCap":334650000},{"date":"2021-09-03","current":-3104.82751,"twenty":-3127.187378,"median":-3104.82751,"eighty":-3098.438976,"marketCap":335340000},{"date":"2021-09-10","current":-3108.021777,"twenty":-3127.187378,"median":-3104.82751,"eighty":-3098.438976,"marketCap":335685000},{"date":"2021-09-17","current":-3108.021777,"twenty":-3126.548525,"median":-3104.82751,"eighty":-3098.438976,"marketCap":335685000},{"date":"2021-09-24","current":-3109.61891,"twenty":-3123.993111,"median":-3104.82751,"eighty":-3098.438976,"marketCap":335857500},{"date":"2021-10-01","current":-3088.856175,"twenty":-3123.993111,"median":-3104.82751,"eighty":-3098.438976,"marketCap":333615000},{"date":"2021-10-08","current":-3127.187378,"twenty":-3123.993111,"median":-3108.021777,"eighty":-3098.438976,"marketCap":337755000},{"date":"2021-10-15","current":-3111.216044,"twenty":-3126.548525,"median":-3108.021777,"eighty":-3098.438976,"marketCap":336030000},{"date":"2021-10-22","current":-3120.798845,"twenty":-3123.993111,"median":-3108.021777,"eighty":-3098.438976,"marketCap":337065000},{"date":"2021-10-29","current":-3120.798845,"twenty":-3123.993111,"median":-3108.021777,"eighty":-3098.438976,"marketCap":337065000},{"date":"2021-11-05","current":-3117.604578,"twenty":-3123.993111,"median":-3108.021777,"eighty":-3098.438976,"marketCap":336720000},{"date":"2021-11-12","current":-3123.993111,"twenty":-3123.993111,"median":-3108.021777,"eighty":-3098.438976,"marketCap":337410000},{"date":"2021-11-19","current":-3120.798845,"twenty":-3123.993111,"median":-3108.021777,"eighty":-3098.438976,"marketCap":337065000},{"date":"2021-11-26","current":-3127.187378,"twenty":-3123.993111,"median":-3109.61891,"eighty":-3098.438976,"marketCap":337755000},{"date":"2021-12-03","current":-3127.187378,"twenty":-3127.187378,"median":-3111.216044,"eighty":-3098.438976,"marketCap":337755000},{"date":"2021-12-10","current":-3123.993111,"twenty":-3127.187378,"median":-3111.216044,"eighty":-3098.438976,"marketCap":337410000},{"date":"2021-12-17","current":-3123.993111,"twenty":-3127.187378,"median":-3111.216044,"eighty":-3098.438976,"marketCap":337410000},{"date":"2021-12-23","current":-3114.410311,"twenty":-3127.187378,"median":-3112.813178,"eighty":-3098.438976,"marketCap":336375000},{"date":"2021-12-31","current":-3127.187378,"twenty":-3127.187378,"median":-3114.410311,"eighty":-3100.99439,"marketCap":337755000},{"date":"2022-01-07","current":-3127.187378,"twenty":-3127.187378,"median":-3114.410311,"eighty":-3101.633243,"marketCap":337755000},{"date":"2022-01-14","current":-3124.919449,"twenty":-3127.187378,"median":-3114.410311,"eighty":-3101.633243,"marketCap":337510050},{"date":"2022-01-21","current":-3111.216044,"twenty":-3127.187378,"median":-3114.410311,"eighty":-3101.633243,"marketCap":336030000},{"date":"2022-01-28","current":-3108.021777,"twenty":-3127.187378,"median":-3114.410311,"eighty":-3101.633243,"marketCap":335685000},{"date":"2022-02-04","current":-3119.201711,"twenty":-3127.187378,"median":-3114.410311,"eighty":-3101.633243,"marketCap":336892500},{"date":"2022-02-11","current":-3120.798845,"twenty":-3127.187378,"median":-3114.410311,"eighty":-3101.633243,"marketCap":337065000},{"date":"2022-02-18","current":-3117.604578,"twenty":-3127.187378,"median":-3114.410311,"eighty":-3101.633243,"marketCap":336720000},{"date":"2022-02-25","current":-3114.410311,"twenty":-3127.187378,"median":-3114.410311,"eighty":-3101.633243,"marketCap":336375000},{"date":"2022-03-04","current":-3120.798845,"twenty":-3127.187378,"median":-3114.410311,"eighty":-3101.633243,"marketCap":337065000},{"date":"2022-03-11","current":-3123.993111,"twenty":-3127.187378,"median":-3114.410311,"eighty":-3102.272096,"marketCap":337410000},{"date":"2022-03-18","current":-3123.993111,"twenty":-3127.187378,"median":-3116.869896,"eighty":-3103.230376,"marketCap":337410000},{"date":"2022-03-25","current":-3114.410311,"twenty":-3127.187378,"median":-3117.604578,"eighty":-3103.86923,"marketCap":336375000},{"date":"2022-04-01","current":-3133.575912,"twenty":-3127.187378,"median":-3117.604578,"eighty":-3104.82751,"marketCap":338445000},{"date":"2022-04-08","current":41.172137,"twenty":-3127.187378,"median":-3117.604578,"eighty":-3101.633243,"marketCap":339480000},{"date":"2022-04-14","current":41.172137,"twenty":-3127.187378,"median":-3116.135215,"eighty":-3101.633243,"marketCap":339480000},{"date":"2022-04-22","current":41.213979,"twenty":-3127.187378,"median":-3114.410311,"eighty":-3101.633243,"marketCap":339825000},{"date":"2022-04-29","current":41.255821,"twenty":-3127.187378,"median":-3114.410311,"eighty":-3098.438976,"marketCap":340170000},{"date":"2022-05-06","current":41.172137,"twenty":-3127.187378,"median":-3114.410311,"eighty":-3098.438976,"marketCap":339480000},{"date":"2022-05-13","current":41.004771,"twenty":-3127.187378,"median":-3114.410311,"eighty":-3098.438976,"marketCap":338100000},{"date":"2022-05-20","current":57.959372,"twenty":-3127.187378,"median":-3114.410311,"eighty":-3098.438976,"marketCap":338445000},{"date":"2022-05-27","current":58.018454,"twenty":-3127.187378,"median":-3114.410311,"eighty":-3095.244709,"marketCap":338790000},{"date":"2022-06-03","current":58.107077,"twenty":-3127.187378,"median":-3114.410311,"eighty":-3095.244709,"marketCap":339307500},{"date":"2022-06-10","current":58.166159,"twenty":-3127.187378,"median":-3114.410311,"eighty":-3092.050442,"marketCap":339652500},{"date":"2022-06-17","current":58.077536,"twenty":-3127.187378,"median":-3114.410311,"eighty":-3085.661908,"marketCap":339135000},{"date":"2022-06-24","current":58.077536,"twenty":-3127.187378,"median":-3111.216044,"eighty":-3085.661908,"marketCap":339135000},{"date":"2022-07-01","current":58.077536,"twenty":-3125.373035,"median":-3111.216044,"eighty":-2418.330905,"marketCap":339135000},{"date":"2022-07-08","current":58.136618,"twenty":-3124.919449,"median":-3111.216044,"eighty":41.130296,"marketCap":339480000},{"date":"2022-07-15","current":58.1957,"twenty":-3124.382812,"median":-3111.216044,"eighty":41.130296,"marketCap":339825000},{"date":"2022-07-22","current":58.254781,"twenty":-3124.005888,"median":-3111.216044,"eighty":41.172137,"marketCap":340170000},{"date":"2022-07-29","current":58.491109,"twenty":-3123.993111,"median":-3109.61891,"eighty":41.172137,"marketCap":341550000},{"date":"2022-08-05","current":58.461568,"twenty":-3123.993111,"median":-3108.021777,"eighty":41.172137,"marketCap":341377500},{"date":"2022-08-19","current":22.59473,"twenty":-3123.993111,"median":-3108.021777,"eighty":41.172137,"marketCap":342240000},{"date":"2022-08-22","current":22.560564,"twenty":-3123.993111,"median":-3108.021777,"eighty":41.172137,"marketCap":341722500},{"date":"2022-08-31","current":22.571953,"twenty":-3123.993111,"median":-3108.021777,"eighty":41.172137,"marketCap":341895000},{"date":"2022-09-06","current":22.59473,"twenty":-3123.993111,"median":-3108.021777,"eighty":41.172137,"marketCap":342240000},{"date":"2022-09-16","current":22.640284,"twenty":-3123.993111,"median":-3108.021777,"eighty":41.172137,"marketCap":342930000},{"date":"2022-09-23","current":22.685838,"twenty":-3123.993111,"median":-3108.021777,"eighty":41.172137,"marketCap":343620000},{"date":"2022-09-30","current":22.663061,"twenty":-3123.993111,"median":-3108.021777,"eighty":41.172137,"marketCap":343275000},{"date":"2022-10-07","current":22.731391,"twenty":-3123.993111,"median":-3108.021777,"eighty":41.172137,"marketCap":344310000},{"date":"2022-10-14","current":22.731391,"twenty":-3123.993111,"median":-3108.021777,"eighty":41.172137,"marketCap":344310000},{"date":"2022-10-21","current":22.754168,"twenty":-3123.993111,"median":-3104.82751,"eighty":41.172137,"marketCap":344655000},{"date":"2022-10-28","current":22.776945,"twenty":-3123.993111,"median":-3104.82751,"eighty":41.172137,"marketCap":345000000},{"date":"2022-11-04","current":22.822499,"twenty":-3123.993111,"median":-3104.82751,"eighty":41.172137,"marketCap":345690000},{"date":"2022-11-10","current":22.822499,"twenty":-3123.993111,"median":-3104.82751,"eighty":41.172137,"marketCap":345690000},{"date":"2022-11-18","current":26.359912,"twenty":-3123.993111,"median":-3104.82751,"eighty":41.130296,"marketCap":346035000},{"date":"2022-11-25","current":26.386193,"twenty":-3123.993111,"median":-3104.82751,"eighty":41.130296,"marketCap":346380000},{"date":"2022-12-02","current":26.425615,"twenty":-3123.993111,"median":-3103.230376,"eighty":41.130296,"marketCap":346897500},{"date":"2022-12-09","current":26.412474,"twenty":-3123.993111,"median":-3101.633243,"eighty":41.130296,"marketCap":346725000},{"date":"2022-12-16","current":26.420096,"twenty":-3123.993111,"median":-3101.633243,"eighty":41.130296,"marketCap":346825050},{"date":"2022-12-23","current":26.438755,"twenty":-3123.993111,"median":-3101.633243,"eighty":41.130296,"marketCap":347070000},{"date":"2022-12-30","current":26.465036,"twenty":-3123.993111,"median":-3101.633243,"eighty":41.121928,"marketCap":347415000}],"updateTime":1746338580633}}}